Dermalogica Aarhus ApS — Credit Rating and Financial Key Figures
CVR number: 21772739
Jens Juuls Vej 22, 8260 Viby J
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 1 440.88 | 1 033.33 | 1 612.04 | 1 534.93 | 1 947.13 |
Employee benefit expenses | -1 824.65 | -1 640.51 | -1 449.38 | -1 504.51 | -1 482.10 |
Total depreciation | -44.52 | - 420.74 | - 434.29 | - 436.69 | |
EBIT | - 383.77 | - 651.69 | - 258.09 | - 403.88 | 28.35 |
Other financial income | 0.15 | 1.69 | |||
Other financial expenses | -0.84 | -1.70 | -5.60 | -12.18 | -0.82 |
Pre-tax profit | - 384.61 | - 653.39 | - 263.54 | - 416.06 | 29.22 |
Income taxes | 84.61 | 143.75 | 57.98 | 91.53 | -6.60 |
Net earnings | - 299.99 | - 509.65 | - 205.56 | - 324.52 | 22.62 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Goodwill | 207.66 | 163.63 | 119.60 | 75.57 | |
Intangible assets total | 207.66 | 163.63 | 119.60 | 75.57 | |
Buildings | 1 850.38 | 1 473.66 | 1 163.06 | 770.40 | |
Tangible assets total | 1 850.38 | 1 473.66 | 1 163.06 | 770.40 | |
Other receivables | 247.66 | 82.60 | 82.60 | 82.60 | 95.98 |
Investments total | 247.66 | 82.60 | 82.60 | 82.60 | 95.98 |
Long term receivables total | |||||
Finished products/goods | 236.60 | 245.86 | 286.95 | 292.89 | 398.77 |
Inventories total | 236.60 | 245.86 | 286.95 | 292.89 | 398.77 |
Current amounts owed by group member comp. | 56.27 | 90.07 | |||
Current other receivables | 6.41 | 221.63 | 19.66 | 15.44 | 31.85 |
Current deferred tax assets | 92.48 | 225.17 | 56.27 | 33.80 | |
Short term receivables total | 98.88 | 446.81 | 75.93 | 105.50 | 121.92 |
Cash and bank deposits | 392.79 | 225.25 | 1 301.44 | 234.91 | 1 239.60 |
Cash and cash equivalents | 392.79 | 225.25 | 1 301.44 | 234.91 | 1 239.60 |
Balance sheet total (assets) | 975.94 | 3 058.55 | 3 384.21 | 1 998.56 | 2 702.23 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 128.00 | 128.00 | 128.00 | 128.00 | 128.00 |
Retained earnings | - 195.12 | - 495.12 | -1 004.76 | -1 210.32 | -1 534.85 |
Profit of the financial year | - 299.99 | - 509.65 | - 205.56 | - 324.52 | 22.62 |
Shareholders equity total | - 367.12 | - 876.76 | -1 082.32 | -1 406.84 | -1 384.22 |
Provisions | 75.53 | 73.82 | 72.36 | 70.02 | |
Non-current other liabilities | 20.23 | 43.77 | |||
Non-current liabilities total | 20.23 | 43.77 | |||
Advances received | 443.37 | 447.21 | 426.53 | 360.59 | 329.77 |
Current trade creditors | 22.53 | 22.53 | 22.53 | 351.08 | |
Current owed to group member | 475.50 | 3 155.64 | 3 604.09 | 2 659.82 | 3 077.23 |
Short-term deferred tax liabilities | 8.93 | ||||
Other non-interest bearing current liabilities | 403.95 | 190.63 | 339.56 | 290.11 | 249.43 |
Current liabilities total | 1 322.82 | 3 816.01 | 4 392.72 | 3 333.05 | 4 016.44 |
Balance sheet total (liabilities) | 975.94 | 3 058.55 | 3 384.21 | 1 998.56 | 2 702.23 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.